| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-071907 |
| cik | 1501796 |
| name | AURA BIOSCIENCES, INC. |
| sic | 2836 |
| countryba | US |
| stprba | MA |
| cityba | BOSTON |
| zipba | 02135 |
| bas1 | 80 GUEST STREET |
| bas2 | |
| baph | (617)500-8864 |
| countryma | US |
| stprma | MA |
| cityma | BOSTON |
| zipma | 02135 |
| mas1 | 80 GUEST STREET |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 320271970 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250515 |
| accepted | 2025-05-15 06:05:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | aura-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-071907 | 20250331 | Operating Lease Liability Noncurrent | 15272000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Operating Income Loss | -29035000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Stockholders Equity | 208783000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Other Assets Noncurrent | 518000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Other Assets Noncurrent | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Accrued Expenses And Other Current Liabilities | 9460000.0000 | USD | 0 | 0000950170-25-071907 | |||
| 0000950170-25-071907 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 263000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 105000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Additional Paid In Capital | 529571000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2909000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2909000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-071907 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 32461000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Common Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-071907 | 20240331 | Comprehensive Income Net Of Tax | -20227000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -27465000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Income Tax Expense Benefit | 46000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Liabilities | 27435000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Liabilities Current | 14913000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Marketable Securities | 89765000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Net Cash Provided By Used In Financing Activities | 96000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Net Income Loss | -27483000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-071907 | 20250331 | Non Cash Lease Expense | 374000.0000 | USD | 1 | 0000950170-25-071907 | |||
| 0000950170-25-071907 | 20240331 | Operating Income Loss | -22313000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -137000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Other Nonoperating Income Expense | -24000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Payments To Acquire Marketable Securities | 29201000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Payments To Acquire Property Plant And Equipment | 187000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Proceeds From Sale Of Marketable Securities | -38685000.0000 | USD | 1 | 0000950170-25-071907 | |||
| 0000950170-25-071907 | 20240331 | Research And Development Expense | 0.0000 | USD | 1 | us-gaap/2024 | Legal Entity= L I C O R Inc; Type Of Arrangement= Exclusive License And Supply Agreement; | ||
| 0000950170-25-071907 | 20250331 | Retained Earnings Accumulated Deficit | -401710000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 51180.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-071907 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 96000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Earnings Per Share Diluted | -0.5500 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Increase Decrease In Prepaid Expenses Other | -3003000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Net Cash Provided By Used In Investing Activities | 29813000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Operating Lease Right Of Use Asset | 17005000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Prepaid Expense And Other Assets Current | 6526000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Proceeds From Sale And Maturity Of Marketable Securities | 30000000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Profit Loss | -19706000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Research And Development Expense | 0.0000 | USD | 1 | us-gaap/2024 | Legal Entity= L I C O R Inc; Type Of Arrangement= Exclusive License And Supply Agreement; | ||
| 0000950170-25-071907 | 20250331 | Share Based Compensation | 3514000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20231231 | Stockholders Equity | 225848000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Stockholders Equity | 263000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-071907 | 20250331 | Stockholders Equity | 127966000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -521000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-071907 | 20250331 | Common Stock Shares Issued | 50225312.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Stockholders Equity | 105000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-071907 | 20250331 | Stockholders Equity | -401710000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-071907 | 20240331 | Stock Issued During Period Shares Employee Stock Purchase Plans | 12314.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-071907 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 49451943.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Accounts Payable Current | 2304000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Common Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-071907 | 20250331 | Adjustments To Additional Paid In Capital Other | 27000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Adjustments To Additional Paid In Capital Other | 27000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-071907 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 27047000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 27047000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Earnings Per Share Diluted | -0.4000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Increase Decrease In Accrued Liabilities | -2895000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Increase Decrease In Operating Lease Liability | -237000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Liabilities And Stockholders Equity | 155401000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Marketable Securities | 119401000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Marketable Securities Gain Loss Excluding Other Than Temporary Impairments | 501000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Net Cash Provided By Used In Financing Activities | 253000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Net Cash Provided By Used In Investing Activities | 9396000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Net Income Loss | -19706000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Operating Costs And Expenses | 29035000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Operating Lease Right Of Use Asset | 17379000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -21000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -521000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Payments To Acquire Marketable Securities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Proceeds From Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Research And Development Expense | 17052000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Restricted Cash And Cash Equivalents Noncurrent | 768000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Restricted Cash And Cash Equivalents Noncurrent | 768000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Stockholders Equity | 18000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-071907 | 20250331 | Stock Issued During Period Shares Employee Stock Purchase Plans | 15263.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-071907 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | 211770.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-071907 | 20250331 | Nonoperating Income Expense | 1570000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -521000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Accrued Expenses And Other Current Liabilities | 6985000.0000 | USD | 0 | 0000950170-25-071907 | |||
| 0000950170-25-071907 | 20241231 | Assets Current | 160623000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Cash And Cash Equivalents At Carrying Value | 26279000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Cash And Cash Equivalents At Carrying Value | 38226000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-071907 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Common Stock Shares Authorized | 150000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Earnings Per Share Basic | -0.5500 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Increase Decrease In Accounts Payable | 23000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Increase Decrease In Other Noncurrent Assets | -56000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Interest Income Expense After Provision For Loan Loss | 1594000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Net Cash Provided By Used In Operating Activities | -24452000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Net Cash Provided By Used In Operating Activities | -23355000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -137000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-071907 | 20240331 | Proceeds From Stock Options Exercised | 158000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Proceeds From Stock Plans | 95000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Research And Development Expense | 11499000.0000 | USD | 1 | us-gaap/2024 | Research And Development Arrangement Contract To Perform For Others By Type= Clinical Preclinical And Research And Development Operations; | ||
| 0000950170-25-071907 | 20250331 | Research And Development Expense | 23343000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Research And Development Expense | 16386000.0000 | USD | 1 | us-gaap/2024 | Research And Development Arrangement Contract To Perform For Others By Type= Clinical Preclinical And Research And Development Operations; | ||
| 0000950170-25-071907 | 20241231 | Retained Earnings Accumulated Deficit | -374227000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20231231 | Stockholders Equity | 539000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-071907 | 20241231 | Stockholders Equity | 151970000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Stockholders Equity | -374227000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-071907 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 96000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-071907 | 20250331 | Assets | 155401000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Assets Current | 134517000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Cash And Cash Equivalents At Carrying Value | 31693000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Depreciation | 306000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | General And Administrative Expense | 5261000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -19660000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Non Cash Lease Expense | 353000.0000 | USD | 1 | 0000950170-25-071907 | |||
| 0000950170-25-071907 | 20240331 | Nonoperating Income Expense | 2653000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Other Operating Activities Cash Flow Statement | -5000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Research And Development Expense | 5553000.0000 | USD | 1 | us-gaap/2024 | Research And Development Arrangement Contract To Perform For Others By Type= Chemistry Manufacturing And Controls; | ||
| 0000950170-25-071907 | 20241231 | Shares Outstanding | 49998279.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-071907 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 49451943.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 50126148.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 158000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -14803000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 6554000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Depreciation | 291000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Earnings Per Share Basic | -0.4000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Increase Decrease In Prepaid Expenses Other | 3750000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Liabilities And Stockholders Equity | 182503000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Liabilities Current | 12163000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Net Income Loss | -19706000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-071907 | 20240331 | Payments To Acquire Property Plant And Equipment | 88000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Proceeds From Stock Plans | 96000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Share Based Compensation | 2909000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Shares Outstanding | 49504405.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-071907 | 20250331 | Shares Outstanding | 50225312.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-071907 | 20231231 | Stockholders Equity | 512617000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-071907 | 20240331 | Stockholders Equity | 515779000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-071907 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 158000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-071907 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 50126148.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Accounts Payable Current | 2006000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Assets | 182503000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Capital Expenditures Incurred But Not Yet Paid | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 41850000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Common Stock Shares Issued | 49998279.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Common Stock Shares Outstanding | 49998279.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Comprehensive Income Net Of Tax | -27641000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -21000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Income Tax Expense Benefit | 18000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Increase Decrease In Accounts Payable | -298000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Increase Decrease In Accrued Liabilities | -2475000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Increase Decrease In Operating Lease Liability | -325000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Increase Decrease In Other Noncurrent Assets | -518000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Interest Income Expense After Provision For Loan Loss | 2685000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Liabilities | 30533000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Marketable Securities Gain Loss Excluding Other Than Temporary Impairments | 1506000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -21000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-071907 | 20250331 | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -158000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Other Nonoperating Income Expense | -32000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Other Operating Activities Cash Flow Statement | 27000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Proceeds From Sale And Maturity Of Marketable Securities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Property Plant And Equipment Net | 3215000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Research And Development Expense | 6957000.0000 | USD | 1 | us-gaap/2024 | Research And Development Arrangement Contract To Perform For Others By Type= Chemistry Manufacturing And Controls; | ||
| 0000950170-25-071907 | 20240331 | Stockholders Equity | -307014000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-071907 | 20250331 | Profit Loss | -27483000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Property Plant And Equipment Net | 3111000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Restricted Cash And Cash Equivalents Noncurrent | 768000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20231231 | Shares Outstanding | 49350788.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-071907 | 20231231 | Stockholders Equity | -287308000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-071907 | 20241231 | Additional Paid In Capital | 525934000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3514000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3514000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-071907 | 20240331 | Capital Expenditures Incurred But Not Yet Paid | 122000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 38994000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 38994000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-071907 | 20241231 | Common Stock Shares Authorized | 150000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Common Stock Shares Outstanding | 50225312.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | General And Administrative Expense | 5692000.0000 | USD | 1 | us-gaap/2024 | Includes depreciation expense directly allocated to respective activities. | ||
| 0000950170-25-071907 | 20250331 | Net Income Loss | -27483000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Operating Costs And Expenses | 22313000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Operating Lease Liability Current | 3149000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Operating Lease Liability Current | 3172000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Operating Lease Liability Noncurrent | 15620000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20241231 | Prepaid Expense And Other Assets Current | 9529000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20250331 | Proceeds From Sale Of Marketable Securities | 0.0000 | USD | 1 | 0000950170-25-071907 | |||
| 0000950170-25-071907 | 20241231 | Stockholders Equity | 525934000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-071907 | 20250331 | Stockholders Equity | 529571000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-071907 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Gross | 90123.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-071907 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 95000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-071907 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 95000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
| Increase Decrease In Prepaid Expenses Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expenses, Other | Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Gross | Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. | |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Interest Income Expense After Provision For Loan Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income (Expense), after Provision for Loan Loss | Amount of interest income or expense, including any amortization and accretion (as applicable) of discounts and premiums, including consideration of the provisions for loan, lease, credit, and other related losses. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Other Operating Activities Cash Flow Statement | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Operating Activities, Cash Flow Statement | Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities). |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Employee Stock Purchase Plan | Aggregate change in value for stock issued during the period as a result of employee stock purchase plan. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Adjustments To Additional Paid In Capital Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Adjustments to Additional Paid in Capital, Other | Amount of other increase (decrease) in additional paid in capital (APIC). |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Marketable Securities Gain Loss Excluding Other Than Temporary Impairments | us-gaap/2024 | 0 | 0 | monetary | D | C | Marketable Security, Gain (Loss) | Amount of realized and unrealized gain (loss) on investment in marketable security. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Non Cash Lease Expense | 0000950170-25-071907 | 1 | 0 | monetary | D | D | Non-cash Lease Expense | Non-cash lease expense. |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
| Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Marketable Securities | The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities | Amount of investment in marketable security. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. |
| Accrued Expenses And Other Current Liabilities | 0000950170-25-071907 | 1 | 0 | monetary | I | C | Accrued Expenses And Other Current Liabilities | Accrued expenses and other current liabilities. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | Amount after tax of other comprehensive income (loss) attributable to parent entity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Proceeds From Stock Plans | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Plans | The cash inflow associated with the amount received from the stock plan during the period. |
| Proceeds From Sale Of Marketable Securities | 0000950170-25-071907 | 1 | 0 | monetary | D | C | Proceeds from sale of marketable securities | Proceeds from sale of marketable securities. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Operating Costs And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Costs and Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Payments To Acquire Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Restricted Cash And Cash Equivalents Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash and Cash Equivalents, Noncurrent | Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Stock Issued During Period Shares Employee Stock Purchase Plans | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Employee Stock Purchase Plans | Number of shares issued during the period as a result of an employee stock purchase plan. | |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-071907 | 2 | 5 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-071907 | 2 | 6 | BS | 0 | H | Marketable Securities | us-gaap/2024 | Marketable securities | 0 |
| 0000950170-25-071907 | 2 | 7 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0000950170-25-071907 | 2 | 8 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-071907 | 2 | 9 | BS | 0 | H | Restricted Cash And Cash Equivalents Noncurrent | us-gaap/2024 | Restricted cash and deposits | 0 |
| 0000950170-25-071907 | 2 | 10 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Right-of-use assets - operating lease | 0 |
| 0000950170-25-071907 | 2 | 11 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other long-term assets | 0 |
| 0000950170-25-071907 | 2 | 12 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0000950170-25-071907 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total Assets | 0 |
| 0000950170-25-071907 | 2 | 16 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-071907 | 2 | 17 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Short-term operating lease liability | 0 |
| 0000950170-25-071907 | 2 | 18 | BS | 0 | H | Accrued Expenses And Other Current Liabilities | 0000950170-25-071907 | Accrued expenses and other current liabilities | 0 |
| 0000950170-25-071907 | 2 | 19 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-071907 | 2 | 20 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Long-term operating lease liability | 0 |
| 0000950170-25-071907 | 2 | 21 | BS | 0 | H | Liabilities | us-gaap/2024 | Total Liabilities | 0 |
| 0000950170-25-071907 | 2 | 22 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and Contingencies (Note 12) | 0 |
| 0000950170-25-071907 | 2 | 24 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.00001 par value, 150,000,000 authorized at March 31, 2025 and December 31, 2024, and 50,225,312 and 49,998,279 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0000950170-25-071907 | 2 | 25 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-071907 | 2 | 26 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0000950170-25-071907 | 2 | 27 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income | 0 |
| 0000950170-25-071907 | 2 | 28 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total Stockholders' Equity | 0 |
| 0000950170-25-071907 | 2 | 29 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total Liabilities and Stockholders' Equity | 0 |
| 0000950170-25-071907 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0000950170-25-071907 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0000950170-25-071907 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0000950170-25-071907 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0000950170-25-071907 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0000950170-25-071907 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0000950170-25-071907 | 4 | 4 | IS | 0 | H | Operating Costs And Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0000950170-25-071907 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Total operating loss | 0 |
| 0000950170-25-071907 | 4 | 7 | IS | 0 | H | Interest Income Expense After Provision For Loan Loss | us-gaap/2024 | Interest income, including amortization and accretion income | 0 |
| 0000950170-25-071907 | 4 | 8 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other expense | 0 |
| 0000950170-25-071907 | 4 | 9 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other income | 0 |
| 0000950170-25-071907 | 4 | 10 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income taxes | 0 |
| 0000950170-25-071907 | 4 | 11 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax provision, net | 1 |
| 0000950170-25-071907 | 4 | 12 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-071907 | 4 | 13 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per common share - basic | 0 |
| 0000950170-25-071907 | 4 | 14 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per common share - diluted | 0 |
| 0000950170-25-071907 | 4 | 15 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average common stock outstanding - basic | 0 |
| 0000950170-25-071907 | 4 | 16 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average common stock outstanding - diluted | 0 |
| 0000950170-25-071907 | 4 | 18 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-071907 | 4 | 20 | IS | 0 | H | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2024 | Unrealized loss on marketable securities | 0 |
| 0000950170-25-071907 | 4 | 21 | IS | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Currency translation adjustment | 0 |
| 0000950170-25-071907 | 4 | 22 | IS | 0 | H | Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | us-gaap/2024 | Total other comprehensive loss | 0 |
| 0000950170-25-071907 | 4 | 23 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Total comprehensive loss | 0 |
| 0000950170-25-071907 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning Balance | 0 |
| 0000950170-25-071907 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning Balance, Shares | 0 |
| 0000950170-25-071907 | 5 | 11 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0000950170-25-071907 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2024 | Employee Stock Purchase Plan issuance | 0 |
| 0000950170-25-071907 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Shares Employee Stock Purchase Plans | us-gaap/2024 | Employee Stock Purchase Plan issuance, Shares | 0 |
| 0000950170-25-071907 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Stock option exercises | 0 |
| 0000950170-25-071907 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Stock option exercises, Shares | 0 |
| 0000950170-25-071907 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | Vesting of restricted stock, Shares | 0 |
| 0000950170-25-071907 | 5 | 17 | EQ | 0 | H | Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | us-gaap/2024 | Unrealized loss on marketable securities | 0 |
| 0000950170-25-071907 | 5 | 18 | EQ | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Currency translation adjustment | 0 |
| 0000950170-25-071907 | 5 | 19 | EQ | 0 | H | Adjustments To Additional Paid In Capital Other | us-gaap/2024 | Other | 0 |
| 0000950170-25-071907 | 5 | 20 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-071907 | 5 | 21 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending Balance | 0 |
| 0000950170-25-071907 | 5 | 22 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending Balance, Shares | 0 |
| 0000950170-25-071907 | 6 | 6 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-071907 | 6 | 8 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation expense | 0 |
| 0000950170-25-071907 | 6 | 9 | CF | 0 | H | Marketable Securities Gain Loss Excluding Other Than Temporary Impairments | us-gaap/2024 | Accretion on marketable securities | 1 |
| 0000950170-25-071907 | 6 | 10 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0000950170-25-071907 | 6 | 11 | CF | 0 | H | Other Operating Activities Cash Flow Statement | us-gaap/2024 | Other | 0 |
| 0000950170-25-071907 | 6 | 12 | CF | 0 | H | Non Cash Lease Expense | 0000950170-25-071907 | Non-cash lease expense | 0 |
| 0000950170-25-071907 | 6 | 14 | CF | 0 | H | Increase Decrease In Prepaid Expenses Other | us-gaap/2024 | Prepaid expenses and other assets | 1 |
| 0000950170-25-071907 | 6 | 15 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2024 | Other long-term assets | 1 |
| 0000950170-25-071907 | 6 | 16 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-071907 | 6 | 17 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses and other liabilities | 0 |
| 0000950170-25-071907 | 6 | 18 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Operating lease liabilities | 0 |
| 0000950170-25-071907 | 6 | 19 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0000950170-25-071907 | 6 | 21 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
| 0000950170-25-071907 | 6 | 22 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2024 | Purchases of marketable securities | 1 |
| 0000950170-25-071907 | 6 | 23 | CF | 0 | H | Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | Maturities of marketable securities | 0 |
| 0000950170-25-071907 | 6 | 24 | CF | 0 | H | Proceeds From Sale Of Marketable Securities | 0000950170-25-071907 | Proceeds from sale of marketable securities | 1 |
| 0000950170-25-071907 | 6 | 25 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by investing activities | 0 |
| 0000950170-25-071907 | 6 | 27 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from exercise of stock options | 0 |
| 0000950170-25-071907 | 6 | 28 | CF | 0 | H | Proceeds From Stock Plans | us-gaap/2024 | Proceeds from ESPP purchases | 0 |
| 0000950170-25-071907 | 6 | 29 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0000950170-25-071907 | 6 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net increase (decrease) in cash, cash equivalents and restricted cash | 0 |
| 0000950170-25-071907 | 6 | 31 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Effect of exchange rate changes on cash and cash equivalents | 0 |
| 0000950170-25-071907 | 6 | 32 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash, cash equivalents and restricted cash at beginning of period | 0 |
| 0000950170-25-071907 | 6 | 33 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash, cash equivalents and restricted cash at end of period | 0 |
| 0000950170-25-071907 | 6 | 35 | CF | 0 | H | Capital Expenditures Incurred But Not Yet Paid | us-gaap/2024 | Purchases of property and equipment in accounts payable and accrued expenses and other liabilities | 0 |
| 0000950170-25-071907 | 7 | 1 | UN | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents, end of period | 0 |
| 0000950170-25-071907 | 7 | 2 | UN | 0 | H | Restricted Cash And Cash Equivalents Noncurrent | us-gaap/2024 | Long-term restricted cash, end of period | 0 |
| 0000950170-25-071907 | 7 | 3 | UN | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash at end of period | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |